Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HMPL-523 Clinical Data Presented at ASH
Investegate announcements from Hutchmed China Ltd, HMPL-523 Clinical Data Presented at ASH
Stay updated with breaking news from Data Presented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Hutchmed China Ltd, HMPL-523 Clinical Data Presented at ASH
14.12.2021 - HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) - HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces new analyses on the ongoing studies of HMPL-523 presented at the 63rd American ... Seite 1
/PRNewswire/ -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today announced updated clinical data from the...
/PRNewswire/ -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today announced updated clinical data from the...
BIRMINGHAM, Ala. and Pensacola, Fla. (PRWEB) December 02, 2021 -- CIRCULOGENE, an innovative medical technology company transforming precision medicine